Inflammatory myofibroblastic tumor of the mesentery: A clinical dilemma

Joseph Shatzel, Kimberly Wooten, Anita Ankola, Richard T. Cheney, Carl D. Morrison, Joseph J. Skitzki

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Although rare, extra-pulmonary inflammatory myofibroblastic tumors (IMTs) are becoming increasingly recognized. While surgical resection is currently an effective and accepted treatment for IMTs, the optimal management of unresectable or residual IMTs remains a clinical dilemma. We present the case of an incompletely resected IMT treated successfully with anti-inflammatory therapy alone, and describe the rationale for this approach.

Original languageEnglish (US)
Pages (from-to)380-384
Number of pages5
JournalInternational Journal of Clinical Oncology
Volume17
Issue number4
DOIs
StatePublished - Aug 1 2012

All Science Journal Classification (ASJC) codes

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Inflammatory myofibroblastic tumor of the mesentery: A clinical dilemma'. Together they form a unique fingerprint.

  • Cite this

    Shatzel, J., Wooten, K., Ankola, A., Cheney, R. T., Morrison, C. D., & Skitzki, J. J. (2012). Inflammatory myofibroblastic tumor of the mesentery: A clinical dilemma. International Journal of Clinical Oncology, 17(4), 380-384. https://doi.org/10.1007/s10147-011-0297-0